The mortality rate for autologous stem cell transplants can differ based on a number of variables that include the patient’s general health, condition treated and specific procedure details. This is why it’s crucial to discuss such issues with a hematologist-oncologist or transplant specialist who can provide personalized details based on the actual medical case. They may present possible data and evaluate the risks-benefits according to separate health condition of this patient or form of treatment for certain illness. It is important to have a broad understanding from an expert in this area.

Approximately 5% of patients who undergo autologous stem cell transplantation (ASCT) experience early mortality (EM), and death within 1 year of transplant (EM post-ASCT).

Disclaimer: This is just for information purposes, we are not promoting stem cells.